Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp > Reminder: The C3 deal with Dermapharm closes Jan 31, this is

<< Previous

Bullboard Posts

Next >>

Comment by Solid1on Jan 29, 2022 2:49pm

111 Views

Post# 34374952

RE:Reminder: The C3 deal with Dermapharm closes Jan 31, this is

Canopy growth bought c3 in 2019 for 225 million euros and now it is being sold again for 80 million euros. I can't understand how such companies can still be called market leaders... but c3 has not given Canopy a big profit in the whole time. I think Labs is better!

<< Previous

Bullboard Posts

Next >>

3 Mid-Sized Stocks to Consider This Season